Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Mar 3;69(2):335-340.
doi: 10.1590/1806-9282.20221445. eCollection 2023.

Hereditary thrombophilia and low -molecular -weight heparin in women: useful determinants, including thyroid dysfunction, incorporating the management of treatment and outcomes of the entity

Affiliations

Hereditary thrombophilia and low -molecular -weight heparin in women: useful determinants, including thyroid dysfunction, incorporating the management of treatment and outcomes of the entity

Stefan Dugalic et al. Rev Assoc Med Bras (1992). .

Abstract

Objective: Our study purposed to examine the complex relationship between low-molecular-weight heparin therapy, multiple pregnancy determinants, and adverse pregnancy outcomes during the third trimester in women with inherited thrombophilia.

Methods: Patients were selected from a prospective cohort of 358 pregnant patients recruited between 2016 and 2018 at the Clinic for Obstetrics and Gynecology, University Clinical Centre of Serbia, Belgrade.

Results: Gestational age at delivery (β=-0.081, p=0.014), resistance index of the umbilical artery (β=0.601, p=0.039), and D-dimer (β=0.245, p<0.001) between 36th and 38th weeks of gestation presented the direct predictors for adverse pregnancy outcomes. The model fit was examined using the root mean square error of approximation 0.00 (95%CI 0.00-0.18), the goodness-of-fit index was 0.998, and the adjusted goodness-of-fit index was 0.966.

Conclusion: There is a need for the introduction of more precise protocols for the assessment of hereditary thrombophilias and the need for the introduction of low-molecular-weight heparin.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest: the authors declare there is no conflicts of interest.

Figures

Figure 1
Figure 1. A path model presenting the complex relationship between low-molecular-weight heparin therapy, multiple pregnancy determinants, and adverse pregnancy outcomes during the third trimester in cases with inherited thrombophilia.

References

    1. American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins–Obstetrics ACOG practice bulletin No. 197: inherited thrombophilias in pregnancy. Obstet Gynecol. 2018;132(1):e18–e34. doi: 10.1097/AOG.0000000000002703. - DOI - PubMed
    1. Trasca LF, Patrascu N, Bruja R, Munteanu O, Cirstoiu M, Vinereanu D. Therapeutic implications of inherited thrombophilia in pregnancy. Am J Ther. 2019;26(3):364–374. doi: 10.1097/MJT.0000000000000985. - DOI - PubMed
    1. Dłuski D, Mierzyński R, Poniedziałek-Czajkowska E, Leszczyńska-Gorzelak B. Adverse pregnancy outcomes and inherited thrombophilia. J Perinat Med. 2017;46(4):411–417. doi: 10.1515/jpm-2017-0059. - DOI - PubMed
    1. Hadžić D, Zulić E, Alihodžić H, Softić D, Kovačevic D. Oxygen saturation index for assessment of respiratory failure in neonates. Sanamed. 2018;13(2):123–129. doi: 10.24125/sanamed.v13i2.224. - DOI
    1. Mulrooney JS. Uterine artery Doppler of the gravid uterus as a predictor identifying at-risk pregnancies: a meta-analysis. J Diagnostic Med Sonogr. 2015;31(1):64–69. doi: 10.1177/8756479314563541. - DOI

Substances